We build and deliver a complete commercial engine for companies selling into biotech & pharma. This means market intelligence, AI-scored prospect databases, and multi-channel outreach execution — so your team inherits a working pipeline, not a blank CRM.
Building lists. Finding contacts. Validating emails. Your senior BDs are doing $30/hr work instead of the $300/hr conversations they were hired for.
Your prospects are PhDs and technical experts. They can smell generic outreach a mile away. If the message doesn't reflect their world, it gets deleted.
CRM setup. Domain warming. Tool stack. Hiring SDRs who understand the difference between a CDMO and a CRO. By the time you're running, a quarter has passed.
Most lead gen agencies sell you channels. We sell you a full calendar.
Your senior BDs open their calendar and see qualified meetings with VPs, Directors, and procurement leads who match your ICP. We handle the list building, contact validation, prospect research, and prioritization — all of it. Your reps go back to doing the $300/hr work they were hired for.
Every touchpoint references what your prospect is actually dealing with — their funding round, their scale-up timeline, their regulatory milestone. We track this daily because we live in this market. Your outreach reads like it comes from someone who understands their world, because it does.
We deploy a full commercial engine in 2–4 weeks, which covers everything — CRM, domains, intel stack, targeting, messaging, and live campaigns. That means no new hires to train and no six-month ramp. And after 3 months, you own the entire engine we've built in perpetuity.
"Science 2 Sales took on the repetitive task of prospecting and left our BD reps to handle the detailed sales process. They've consistently delivered high-quality prospect engagement across multiple channels, generating meaningful conversations with decision-makers while reinforcing our team as thought leaders through strategic LinkedIn content."— Head of Sales, Multinational Bioprocess Instrument Manufacturer
You don't need another vendor. You need the commercial engine your biopharma product/services deserves.
Our founder publishes TLDR Biotech — a daily newsletter covering deals, trials, approvals, and funding in biotech and pharma. This gives us credibility and recognition that opens doors.
We can also advertise your company to our newsletter audience — putting your brand in front of 3,000+ industry professionals who are already paying attention to the space.
Read TLDR BiotechMost agencies rent you access to their tools and disappear when the contract ends. We build you a fully custom, AI-powered commercial infrastructure (intel system, database structure, outreach systems) that you own in perpetuity after 3 months. Here's what that includes.
We map your entire addressable market and build a strategic intelligence layer before a single email is sent. This includes competitive analysis, product-market fit validation, buyer segmentation, and ongoing monitoring of clinical trials, funding events, regulatory shifts, and leadership changes across your target market.
We build you a living database of every account and contact in your market, enriched with firmographics, funding history, clinical pipelines, leadership changes, hiring signals, and intent data. AI-powered scoring prioritizes who your team should talk to and why, updating as the market moves.
AI-generated, hyper-personalized email and LinkedIn campaigns grounded in the intelligence layer, with every message pulled from your specific value propositions matched against the prospect's actual situation, company stage, and role — no templates. Each message reads like it was written by someone who understands both their product/service and their world.
A personalized news feed tracking competitive moves, regulatory shifts, and funding events across your buyer graph. Continuous database refreshes as your market evolves. Campaign optimization based on real response data. Pipeline reporting that shows exactly what's working and where to push harder — the system gets sharper every week.
Email and LinkedIn campaigns are essential for coverage and prospect outreach. At the same time, that's what everyone else is doing. Your prospects' inboxes are flooded with AI-generated messages, and standing out is harder than ever.
We maintain a trained team of callers with life sciences context who pick up the phone and have real conversations with your target prospects. These callers are armed with the intelligence layer we've already built — meaning they know what the prospect's company does, where they sit in your priority scoring, and what value prop matters most to that buyer.
Though cold calling is a powerful way to book meetings, it's also the singular most effective way (beyond conference attendance) to speak directly with your prospect and gather primary market intelligence that very few email or LinkedIn DM replies can match.
This is the channel your competitors aren't willing to invest in, which is exactly why it works.
Pipeline built for bioprocess instrumentation, CDMO services, and analytical equipment.
Results from our Founder's work building outbound prospecting workflows at previous employers
"Science 2 Sales took on the repetitive task of prospecting and left our BD reps to handle the detailed sales process. They've consistently delivered high-quality prospect engagement across multiple channels, generating meaningful conversations with decision-makers while reinforcing our team as thought leaders through strategic LinkedIn content."
"Action-oriented and independent, Anis [Founder of Science 2 Sales] hit the ground running and didn't look back in building a robust prospect funnel. He was adept at leveraging the available tools and technologies to effectively target and progress high-value opportunities. Always engaging and easy to work with, Anis demonstrated a facility with both the technical and people skills needed to succeed in this position [Founding Business Development Associate] and beyond."
With a Master's in Chemistry and four years as a founding BDR at companies like Cytiva Aseptic Filling (formerly Vanrx) and OmniaBio — a cell and gene therapy CDMO — he built outbound programs from zero. That means cold calling CEOs and CDMO decision-makers, writing cold email and LinkedIn sequences that landed meetings with VPs of Manufacturing and SVPs of Process Development, and building automation-leveraged workflows before there was a playbook to follow.
The results speak for themselves: $20M+ in qualified pipeline in 7 months at Cytiva, and 39 new opportunities and $71M in CDMO proposals at OmniaBio. All from pure outbound, built by one person who understood both the science and the sell.
Today, he also publishes TLDR Biotech — a daily newsletter read by 3,000+ biotech and pharma professionals every morning. That same market domain knowledge, reputation, and determination drives what we do at Science 2 Sales.
"Action-oriented and independent, Anis hit the ground running and didn't look back in building a robust prospect funnel. He was adept at leveraging the available tools and technologies to effectively target and progress high-value opportunities."— Kyle Ritchie, Director, Business Development, OmniaBio
If your buyer has a PhD or runs a manufacturing line, we speak their language.
A focused engagement that delivers real infrastructure. By the end of the three months, you have a complete commercial system that's yours to keep — whether or not you choose to continue working with us.
We analyze your market, map your competitive landscape, and build your positioning frameworks. ICP definition, buyer persona development, and strategic alignment with your team. Email infrastructure setup and domain warming begins immediately in parallel. You receive your first intelligence deliverables — market research, product-market fit analysis, and buyer segmentation — within the first two weeks.
Your custom AI-scored database goes live — every account and contact in your addressable market, enriched, scored, and prioritized. Your team sees the full landscape of who they can sell to and why each account matters. The outreach engine is wired up and ready.
Multi-channel outreach launches — personalized email sequences, LinkedIn engagement, and cold calling into your highest-priority targets. Qualified meetings start landing in your team's calendar. We optimize continuously based on real response data and market signals.
Everything we built is transferred to you. Database, scoring logic, intelligence reports, dashboards, outreach infrastructure, messaging frameworks — all of it. You own the system outright. Continue working with us for ongoing execution and optimization, or take it in-house and run it yourself. Either way, the asset is yours.
Database. Scoring models. Dashboards. Outreach infrastructure. Intelligence reports. No lock-in. No black box. No "you need us to keep the lights on." It's yours at handover, period.
We're not a lead gen agency. We build you a complete, AI-powered commercial system — market intelligence, a scored prospect database, multi-channel outreach, and pipeline infrastructure — that you own outright. Lead gen agencies rent you activity. We hand you an asset that keeps working whether you stay with us or not.
We work with companies that sell products or services into biotech and pharma — instrument manufacturers, software providers, CROs, CDMOs, reagent companies, analytical services firms, and similar. If your buyer has a PhD or runs a manufacturing line, we speak their language.
At the end of our engagement, we transfer the complete system to you: your scored database of accounts and contacts, the intelligence reports and positioning frameworks, your outreach infrastructure (domains, inboxes, automation workflows), dashboards, and all the underlying logic. There's no proprietary platform you need to keep subscribing to. It's yours to run, modify, or hand to your internal team.
Email infrastructure warming begins in week one. Your intelligence deliverables and scored database are typically ready by weeks two to three. Outreach campaigns begin launching in weeks three to four, with qualified meetings typically landing before the end of the first month. The full system buildout and handover completes by month three.
Four layers of work: (1) Market intelligence and strategic positioning — competitive analysis, product-market fit validation, buyer segmentation. (2) Custom database build — AI-scored accounts and contacts across your full addressable market. (3) Multi-channel execution — personalized email, LinkedIn outreach, and cold calling. (4) Ongoing intelligence — news monitoring, database refreshes, campaign optimization, and pipeline reporting. Everything is built custom for your market and your buyers.
Yes, and it's a core differentiator. We maintain a trained team of callers with life sciences context who can have real conversations with your target prospects. They're equipped with the intelligence from your database — they know the prospect's company, their priority score, and the value prop that matters most. Cold calling cuts through the noise that automated channels can't.
You have two options. Option one: take the full system in-house and run it yourself — you have everything you need. Option two: continue working with us on a monthly basis for ongoing execution, optimization, database refreshes, and market intelligence updates. Most clients stay because the system keeps improving, but the choice is entirely yours.
Every piece of outreach is grounded in the intelligence layer we build during the first phase — your actual value propositions, your competitive positioning, real market signals. Our AI messaging system generates content specific to each prospect's company, role, and situation. No generic templates. And our team includes people with direct life sciences sales experience who understand how technical buyers think.
The more niche, the better this system works. Our intelligence layer can map highly specific markets — particular therapeutic areas, specific equipment categories, regional segments — and the AI scoring ensures you're only reaching the prospects that actually matter. We've worked across bioprocess, analytical instruments, CDMO services, clinical trial software, and more. Book a call and we'll tell you honestly if we can help.
Pricing depends on the scope of your market, the number of channels you want to activate, and whether you want ongoing execution after the initial build. This is an investment in commercial infrastructure, not a monthly retainer for email blasts. Book a strategy call and we'll scope something based on your actual situation.
All of our data sources are GDPR-compliant. The database we build for you uses publicly available business information enriched through compliant data providers. We can structure outreach to meet regional compliance requirements for multiple international markets.
No pitch deck. No pressure. Just an honest look at whether we can help.
Book Your Free Strategy Call